Dennis Matheis Lucid Diagnostics Inc. (LUCD) insider trading activity

LUCD Quotes by TradingView

Dennis Matheis is Director of Lucid Diagnostics Inc.. Currently has a direct ownership of 350,000 shares of LUCD, which is worth approximately $448,000. The most recent transaction as insider was on May 22, 2025, when has been sold 33,218 shares (Common Stock) at a price of $1.32 per share, resulting in proceeds of $43,847. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 350K
115.09% 3M change
n/a 12M change
Total Value Held $448,000

Dennis Matheis Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 22 2025
BUY
Open market or private purchase
$43,847 $1.32 p/Share
33,218 Added 8.67%
350,000 Common Stock
May 21 2025
BUY
Open market or private purchase
$171,182 $1.32 p/Share
129,684 Added 29.05%
316,782 Common Stock
May 20 2025
BUY
Open market or private purchase
$241,356 $1.29 p/Share
187,098 Added 50.0%
187,098 Common Stock
Feb 20 2025
BUY
Grant, award, or other acquisition
-
112,800 Added 40.94%
162,725 Common Stock

Also insider at

DRIO
DarioHealth Corp. Healthcare
Director
DM

Dennis Matheis

Director
Caesarea Industrial Park, L3

Track Institutional and Insider Activities on LUCD

Follow Lucid Diagnostics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LUCD shares.

Notify only if

Insider Trading

Get notified when an Lucid Diagnostics Inc. insider buys or sells LUCD shares.

Notify only if

News

Receive news related to Lucid Diagnostics Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on LUCD